EpiVario

EpiVario Inc. is pioneering epigenetic therapeutic development to redefine treatment landscapes for neuropsychiatric disorders. Spun out of the Epigenetics Institute at the University of Pennsylvania, the company develops innovative therapeutics targeting a newly identified epigenetic process involved in trauma-induced

EpiVario is active in the neuro space.

Profile

EpiVario Inc. is pioneering epigenetic therapeutic development to redefine treatment landscapes for neuropsychiatric disorders. Spun out of the Epigenetics Institute at the University of Pennsylvania, the company develops innovative therapeutics targeting a newly identified epigenetic process involved in trauma-induced fear and stress responses, and addiction-related drug craving. This discovery provides a unique therapeutic target for […]

The company sits in the neuro segment, where it competes on its core product or service.

The company is listed at the Creative Destruction Lab alumni company stage of development.

Website: epivario.com